In this episode, we sit down with Dr Liz Dallimore, who serves as the Chief Executive Officer and Managing Director of Argenica Therapeutics (ASX:AGN). Join us as we delve into the most recent developments and valuable insights within AGN, and take a closer look at what drives Liz's success.

Dr Dallimore has over 20 years’ experience in both biotechnology and management consulting across Australia and the UK. She has held senior roles in management consulting as KPMG’s Australian Director of Research Engagement and Commercialisation, structuring technology commercialisation deals across a range of sectors, with a specific focus on biotechnology. Prior to this Liz held senior management roles with Ernst & Young and PricewaterhouseCoopers in technology advisory and R&D. Prior to moving into management consulting, Liz was a research sc ...